Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Smoking Negatively Impacts Surgical Outcome of Crohn's Disease

By HospiMedica International staff writers
Posted on 14 Apr 2015
A new study suggests that in surgical patients with Crohn's Disease (CD), smoking drives infectious and pulmonary complications and an increased likelihood of readmission.

Researchers at Pennsylvania State University (Hershey, USA) reviewed the US National Surgical Quality Improvement Program (NSQIP) database, identifying 7,631 patients with CD that underwent surgical resection between 2005 and 2012; of these, 2,047 patients were identified as current smokers, and 5,584 identified as non- or ex-smokers. More...
The patients were stratified based on smoking status, with surgical outcomes--such as length of stay (LOS), mortality, postoperative complications, and readmission—evaluated using regression models to assess the influence of smoking.

The results showed that smokers were more likely to have a pulmonary comorbidity, pre-operative weight loss, and a higher American Society of Anesthesiologists (ASA) classification. No differences in mortality were observed between smokers and non- or ex-smokers, and smoking status was not significantly associated with LOS. On the other hand, morbidity, and particularly infectious and pulmonary complications and readmission, were significantly associated with smoking status. The study was published on March 25, 2015, in Colorectal Disease.

Patients suffering from CD, an inflammation and ulceration process that occurs in the deep layers of the intestinal wall, experience pain in the abdomen, often in the lower right side, diarrhea, weight loss, and occasionally bleeding. Smokers with CD may experience more frequent symptom flares. How exactly smoking worsens Crohn’s symptoms remains elusive, but it is suspected that cigarette smoke damages protective mucous membranes in the digestive system, increasing the risk for inflammation.

Related Links:

Pennsylvania State University




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Syringes
Prefilled Saline Flush Syringes
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.